Your Good Partner in Biology Research

肿瘤坏死因子

TNF(全称肿瘤坏死因子,Tumor Necrosis Factor)是一种能够直接杀伤肿瘤细胞而对正常细胞无明显毒性的细胞因子,是迄今为止所发现的直接杀伤肿瘤作用最强的生物活性因子之一。最初是在1975年,由E.A. Carswell等人发现,后于1985年经Shalaby命名,由巨噬细胞产生的TNF命名为TNF-α,而由T淋巴细胞产生的淋巴毒素(lymphotoxin,LT)命名为TNF-β。

虽然TNF-α与TNF-β仅有约30%的同源性,但它们却拥有共同的受体。TNFα的生物学活性占TNF总活性的70 %~95 %,因此目前常说的TNF多指TNF-α。

TNFα是一种涉及到系统性炎症的细胞因子,主要由巨噬细胞分泌。TNFα的主要功能是调节免疫细胞,作为一种内源性致热原,可以导致发热,引起细胞凋亡,组织肿瘤发生和病毒复制,并可以通过刺激细胞分泌IL1和IL6对败血症作出反应。TNFα功能失调涉及多种疾病,比如阿尔兹海默症、银屑病、癌症、重度抑郁和肠炎等。TNF家族除这两种外还发现约30种。

华美生物TNF类蛋白产品涵盖了绝大部分TNF家族成员,这里展示了部分蛋白产品图片:

产品名称 货号 规格
Recombinant Macaca mulatta Tumor necrosis factor protein (TNF), partial, (Active) CSB-AP003221MOW 500ug/100ug/5ug
Recombinant Mouse Tumor necrosis factor protein (Tnf), partial (Active) CSB-AP003471MO 500ug/100ug/5ug
Recombinant Human Lymphotoxin-alpha protein (LTA) CSB-AP002171HU 500ug/100ug/10ug
Recombinant Human Tumor necrosis factor ligand superfamily member 11 (TNFSF11), partial (Active) CSB-AP004851HU 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug
Recombinant Human Tumor necrosis factor (TNF), partial (Active) CSB-AP004861HU 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug
Recombinant Human Tumor necrosis factor (TNF), partial (Active) CSB-AP004871HU 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug
Recombinant Human Tumor necrosis factor (TNF), partial (Active) CSB-AP004881HU 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug
Recombinant Human Tumor necrosis factor receptor superfamily member 1B (TNFRSF1B), partial (Active) CSB-AP004891HU 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug
Recombinant Human Tumor necrosis factor ligand superfamily member 10 (TNFSF10), partial (Active) CSB-AP004901HU 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug
Recombinant Human Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B), partial (Active) CSB-AP004921HU 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug
Recombinant Human Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B), partial (Active) CSB-AP004931HU 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug
Recombinant Human Lymphotoxin-alpha (LTA) (Active) CSB-AP004941HU 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug
Recombinant Human Tumor necrosis factor receptor superfamily member 11B (TNFRSF11B) (Active) CSB-AP004951HU 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug
Recombinant Human Tumor necrosis factor receptor superfamily member 10C (TNFRSF10C), partial (Active) CSB-AP004961HU 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug
Recombinant Human Tumor necrosis factor receptor superfamily member 1A (TNFRSF1A), partial (Active) CSB-AP004971HU 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug
Recombinant Human Tumor necrosis factor receptor superfamily member 10C (TNFRSF10C), partial (Active) CSB-AP004981HU 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug
Recombinant Human Tumor necrosis factor ligand superfamily member 15 (TNFSF15) (Active) CSB-AP004991HU 1mg(1mg*1 or 500ug*2)/500μg/50μg/10μg
Recombinant Mouse Tumor necrosis factor ligand superfamily member 11 (Tnfsf11), partial (Active) CSB-AP005021MO 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug
Recombinant Mouse Tumor necrosis factor (Tnf), partial (Active) CSB-AP005031MO 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug
Recombinant Mouse Tumor necrosis factor receptor superfamily member 10B (Tnfrsf10b), partial (Active) CSB-AP005041MO 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug

正如我们前面所说的,当我们提到TNF时,我们通常指的是TNFα。目前有关TNFα的作用机制已基本明了。 TNFα可以结合两种受体,TNFR1(TNF受体1型)和TNFR2(TNF受体2型)。 TNFR1可在大多数组织中表达,可以与膜上的TNF可溶性三聚体形式结合并活化。而TNFR2通常存在于免疫系统的细胞中,可以与膜结合的TNF同源三聚体形式起作用。但就目前的研究数据而言,大多数关于TNF信号传导均来自TNFR1,而TNFR2的作用就相对较小。TNFα与受体结合后,可激活多条信号通路,包括NFκB和MAPK信号传导途径。

此外,基于TNFα可以杀死肿瘤细胞这一特性, TNFα抑制剂已被用于临床。TNFα抑制剂是一种抑制对TNFα生理反应的药物。TNFα可参与自身免疫和免疫介导疾病,例如类风湿性关节炎、强直性脊柱炎、炎性肠病、牛皮癣、化脓性汗腺炎和难治性哮喘,它本身就是引起炎症的一个重要因素,所有TNF抑制剂可用于这些自身免疫和免疫介导疾病的治疗。目前已上市的TNFα抑制剂包括依那西普、英夫利昔单抗、阿达木单抗、赛妥珠单抗和戈利木单抗,都是通过与TNFα结合来抑制其与对应受体结合起作用。